Document Detail


Effect of hormone therapy on the elastic properties of the arteries in healthy postmenopausal women.
MedLine Citation:
PMID:  15966502     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The aim of the study was to assess the effect of continuous hormone therapy (HT) for 1 yr on pulse wave analysis and central aortic pressure in healthy postmenopausal women. Sixty-five healthy postmenopausal women were randomly allocated to receive either conjugated equine estrogens 0.625 mg plus medroxyprogesterone acetate 5 mg (CEE/MPA, Premelle 5, Wyeth-Ayerst Lab, Philadelphia, PA, no.=32) or no therapy (no.=33). Treatment was continuous, and the study period lasted 12 months. Central aortic pressure, augmentation and augmentation index (AI) were determined non-invasively using applanation tonometry. All measurements were performed at baseline and at the end of the study by the same person. Ns differences were found between baseline values and values at the end of the study in either the control or the CEE/MPA group in central systolic aortic pressure (107.0 +/- 13.1 vs 107.6 +/- 11.3 mmHg, p=0.80, and 110.8 +/- 10.8 vs 112.3 +/- 11.4 mmHg, p=0.23, respectively), augmentation (12.6 +/- 4.2 vs 11.9 +/- 4.8 mmHg, p=0.45 and 11.7 +/- 3.7 vs 12.6 +/- 4.2 mmHg, p=0.34, respectively), and percentage of AI (36.8 +/- 9.3 vs 36.3 +/- 10.3, p=0.81 and 34.1 +/- 8.9 vs 34.9 +/- 9.8, p=0.72, respectively). The results of this preliminary report suggest that HT for 1 yr does not have any significant effect on central aortic pressure and wave reflection in healthy postmenopausal women.
Authors:
N Tentolouris; G Christodoulakos; I Lambrinoudaki; E Mandalaki; C Panoulis; C Maridaki; G Creatsas; N Katsilambros
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Journal of endocrinological investigation     Volume:  28     ISSN:  0391-4097     ISO Abbreviation:  J. Endocrinol. Invest.     Publication Date:  2005 Apr 
Date Detail:
Created Date:  2005-06-21     Completed Date:  2005-08-16     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  7806594     Medline TA:  J Endocrinol Invest     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  305-11     Citation Subset:  IM    
Affiliation:
Department of Propedeutic Medicine, Laiko Hospital, Athens, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aorta / physiology
Arteries / physiology
Blood Pressure
Contraceptive Agents, Female / pharmacology*,  therapeutic use*
Elasticity
Estrogens, Conjugated (USP) / pharmacology*,  therapeutic use*
Female
Hormone Replacement Therapy*
Humans
Medroxyprogesterone Acetate / pharmacology*,  therapeutic use*
Middle Aged
Postmenopause
Prospective Studies
Vascular Resistance
Chemical
Reg. No./Substance:
0/Contraceptive Agents, Female; 0/Estrogens, Conjugated (USP); 71-58-9/Medroxyprogesterone Acetate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The interaction of plasma renin activity and plasma atrial natriuretic peptide in 21-hydroxylase def...
Next Document:  Association between bone mineral density and polymorphisms of the VDR, ERalpha, COL1A1 and CTR genes...